|
|
|
| |
CTSI is now on Facebook!
|
|
|
|
|
|
|
| |
Currently Enrolling
- XL TDR (Nuvasive)
- Freedom Lumbar Disc (AxioMed)
- TRIUMPH (Globus)
|
|
|
|
|
|
|
| |
If you are a new or established patient, please complete our patient
satisfaction survey:
|
|
|
|
|
|
|
|
|
| |
Randall F. Dryer, M.D., of the Central Texas Spine Institute, is a principal
investigator for this multi-center clinical trial to evaluate the Anatomic Facet
Replacement System (AFRS™) for the treatment
of back and leg pain due to lumbar spinal stenosis. Central Texas Spine
Institute is now enrolling candidates for this study.
Although spinal fusion is well accepted as the standard of
care for lumbar spinal stenosis and related spinal instability, it is associated
with a loss of natural motion at the treated area, which may accelerate adjacent
segment degeneration. Facet Joint Replacement has been developed to
provide symptom relief from lumbar spinal stenosis while preserving natural
motion at the treated area.
Patient Eligibility Summary
-
Age 21 to 85
-
Diagnosis of lumbar spinal stenosis at up to 3 levels from L3
to S1, requiring facet replacement at a single L4-L5 level
-
Failure to respond to at least 6-months of non-operative, conservative management
-
Surgical candidate for decompression with facetectomy and fusion
-
Has not had 2 or more surgeries at the operative level
-
Does not have osteoporosis
-
Predominantly afflicted with leg pain
All potential candidates are subject to
the above and additional non-listed clinical trial criteria. If
you are interested in being considered a candidate for the AFRS™ clinical trial, please
visit www.stenosisrelief.com
or contact our study
coordinator, Amy, via email at
studyinfo@pqrinc.com.
Caution:
Investigational device, limited by Federal law to investigational use.
|
|
|
|
|
|
|
| |
Randall F. Dryer, M.D., of Central
Texas Spine Institute, is a principal investigator for this
prospective, randomized, controlled multi-center clinical trial to
valuate the safety and effectiveness of the XL TDR device.
What Is XL TDR?
XL TDR is a metallic prosthetic
joint, or total disc replacement, that replaces a degenerative
intervertebral disc. Like fusion, total disc replacement is designed to
supplant the primary function of the disc – to maintain vertebral spacing
to protect the nerves and spinal cord. Unlike fusion, though, total disc
replacement seeks to maintain one of the secondary functions of the disc –
providing motion in the spine. Once implanted between the vertebrae, XL
TDR is designed to relieve pain and restore height while replicating the
motion characteristics of an intact healthy disc.
If you are interested in being considered a candidate for the XL TDR® clinical trial, please contact our study coordinator, Amy, via email at
studyinfo@pqrinc.com.
Caution:
Investigational device, limited by Federal law to investigational use.
|
|
|
|
|
|
|
|
|
